IRIS
ZAPPAVIGNA, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.818
NA - Nord America 4.344
AS - Asia 3.085
Continente sconosciuto - Info sul continente non disponibili 387
SA - Sud America 377
AF - Africa 55
OC - Oceania 10
Totale 16.076
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 5.036
US - Stati Uniti d'America 4.278
SG - Singapore 1.043
IE - Irlanda 801
IT - Italia 704
CN - Cina 681
VN - Vietnam 443
HK - Hong Kong 364
BR - Brasile 324
GB - Regno Unito 260
DE - Germania 240
UA - Ucraina 230
KR - Corea 186
FR - Francia 138
SE - Svezia 92
FI - Finlandia 88
IN - India 86
JP - Giappone 73
GR - Grecia 72
TR - Turchia 54
BD - Bangladesh 36
CA - Canada 34
PL - Polonia 27
AR - Argentina 23
BG - Bulgaria 23
NL - Olanda 23
PK - Pakistan 22
BE - Belgio 21
ZA - Sudafrica 21
AT - Austria 20
MX - Messico 20
ID - Indonesia 17
ES - Italia 16
MA - Marocco 12
UZ - Uzbekistan 12
IQ - Iraq 11
CO - Colombia 10
EC - Ecuador 10
IR - Iran 10
AU - Australia 8
PH - Filippine 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
KE - Kenya 5
AZ - Azerbaigian 4
DZ - Algeria 4
EU - Europa 4
LT - Lituania 4
SN - Senegal 4
TW - Taiwan 4
AL - Albania 3
CH - Svizzera 3
CL - Cile 3
KZ - Kazakistan 3
MY - Malesia 3
NP - Nepal 3
TN - Tunisia 3
VE - Venezuela 3
AM - Armenia 2
BB - Barbados 2
DK - Danimarca 2
EG - Egitto 2
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
NO - Norvegia 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
JO - Giordania 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
NI - Nicaragua 1
NR - Nauru 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PW - Palau 1
PY - Paraguay 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
Totale 15.693
Salva come PNG Salva come JPEG
Città #
Moscow 1.772
Dublin 801
San Jose 714
Chandler 517
Singapore 493
Santa Clara 465
Jacksonville 363
Hong Kong 360
Dallas 199
Ashburn 179
Seoul 175
Ho Chi Minh City 127
Hefei 117
Naples 113
New York 113
Caserta 98
Beijing 97
Princeton 96
Hanoi 89
Roxbury 83
Medford 73
Los Angeles 67
Bengaluru 62
Boardman 59
Bremen 58
Ann Arbor 54
Dong Ket 54
Council Bluffs 44
The Dalles 43
Munich 39
Des Moines 36
Cambridge 33
Wilmington 33
Aversa 31
Napoli 31
São Paulo 30
Helsinki 27
Orem 26
Nuremberg 25
Woodbridge 25
Mountain View 24
Milan 23
Da Nang 22
San Mateo 22
Brussels 20
Haiphong 19
Rome 17
Warsaw 17
Johannesburg 14
Frankfurt am Main 13
London 13
Mexico City 12
Rio de Janeiro 12
Amsterdam 11
Campodarsego 11
Tashkent 11
Guangzhou 10
Istanbul 10
Madrid 10
San Nicola la Strada 10
Tokyo 10
Denver 9
Falkenstein 9
Houston 9
Jinan 9
Memphis 9
Piscataway 9
San Felice A Cancello 9
Vienna 9
Atlanta 8
Biên Hòa 8
Boston 8
Brooklyn 8
Chicago 8
Jakarta 8
San Francisco 8
Thái Nguyên 8
Changsha 7
Curitiba 7
Düsseldorf 7
Elora 7
Nanjing 7
Phoenix 7
Redwood City 7
Tianjin 7
Xi'an 7
Bologna 6
Cagliari 6
Columbus 6
Hillsboro 6
Montreal 6
Ningbo 6
Ninh Bình 6
Norwalk 6
Philadelphia 6
Seregno 6
Stockholm 6
Thái Bình 6
Auburn Hills 5
Belo Horizonte 5
Totale 8.413
Salva come PNG Salva come JPEG
Nome #
Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure 225
Mitochondria as playmakers of apoptosis, autophagy and senescence 200
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 198
Dicrocoelium dendriticum induces autophagic vacuoles accumulation in human hepatocarcinoma cells 196
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 195
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 193
A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives. 192
Effect of restriction vegan diet's on muscle mass, oxidative status, and myocytes differentiation: A pilot study 191
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures 189
A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells 185
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. 185
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 185
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 184
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 182
The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells 180
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 180
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 180
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 177
Anti-inflammatory drugs as anticancer agents 177
Valutazione in vitro degli effetti cardiotossici da 5-Fluorouracile per la prevenzione dei danni cardiovascolari negli operatori sanitari professionalmente esposti. [Evaluation in vitro of the cardiotoxic effects of 5-fluorouracil for the prevention of cardiovascular damage in health workers occupationally exposed]. 172
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 172
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid. 170
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. 167
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. 166
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 164
Chitosan-based polyelectrolyte complexes for doxorubicin and zoledronic acid combined therapy to overcome multidrug resistance 162
Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx 161
Immune cell infiltration and inflammatory landscape in primary brain tumours 159
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 157
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO 156
MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells 155
Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer 153
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 152
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 151
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 148
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 148
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 147
Bovine serum amine oxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress. 146
Transferrin-targeted nanoparticles containing zoledronic acid as a potential to inhibit glioblastoma growth 146
MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine 146
Self-assembling nanoparticles for delivery of miR-603 and miR-221 in glioblastoma as a new strategy to overcome resistance to temozolomide 145
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 145
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation 144
Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma 142
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 141
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines. 141
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 141
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. 140
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 140
The role of micrornas in development of colitis-associated colorectal cancer 140
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion. 138
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 138
Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer 135
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells 134
Emerging pathways as individualized therapeutic target of multiple myeloma. 134
Poly(ε-caprolactone)-poly(ethylene glycol) Tri-Block Copolymer as Quercetin Delivery System for Human Colorectal Carcinoma Cells: Synthesis, Characterization and In Vitro Study 132
Autophagic cell death: A new frontier in cancer research 131
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 130
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 130
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 127
Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions 127
Characterization of KRAS Mutational Regression in Oligometastatic Patients 126
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 126
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 126
Interleukin 18: Friend or foe in cancer. 124
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 124
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. 123
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 123
CYR61 down-modulation induced by zoledronic acid impairs cell motility and sensitizes prostate cancer cells to docetaxel: A new anti-cancer strategy 123
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 123
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells. 122
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? 122
Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines 121
Measurement of autophagy by flow cytometry 121
Evolutionary conservation of a regulative pathway of erythropoiesis in Poikilothermic vertebrates 120
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance. 120
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts 120
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 120
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes. 119
Drug-drug interactions based on pharmacogenetic profile between highly active antiretroviral therapy and antiblastic chemotherapy in cancer patients with HIV infection 117
Long non-coding RNAs in cancer stem cells 117
Testicular cancer from diagnosis to epigenetic factors 114
Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer 114
Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use 113
Erlotinib: early clinical development in brain cancer. 113
Stealth liposomes for the delivery of zoledronic acid into tumors enhance the anticancer activity of the drug 109
Zoledronic acid encapsulated in self-assembly pegylated nanoparticles as a new delivery system against brain tumors 108
Hepatocarcinoma: genetic and epigenetic features 107
Protein kinase a detection in human urine samples 107
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade 106
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. 105
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells. 105
UROTENSIN II RECEPTOR IS INVOLVED IN THE REGULATION OF MOTILITY OF PROSTATE ADENOCARCINOMA CELLS AND PREDICTS THE CLINICAL OUTCOME OF PROSTATE CANCER PATIENTS 105
LncRNAs and Immunity: Coding the Immune System with Noncoding Oligonucleotides. 105
Ipilimumab for the treatment of metastatic prostate cancer 104
CYR61 DOWN-MODULATION SENSITIZES PROSTATE CANCER CELLS TO ZOLEDRONIC ACID AND DOCETAXEL: A NEW ANTICANCER STRATEGY 100
Nanoparticles releasing zoledronic acid have antitumor activity against experimental models of human glioblastoma 99
Non-coding RNAs as a new dawn in tumor diagnosis 98
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. 97
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. 96
Totale 14.209
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022664 0 11 11 12 206 11 15 22 30 89 50 207
2022/20231.710 155 49 29 193 149 163 3 106 750 23 55 35
2023/2024740 72 32 54 37 202 93 19 20 12 5 51 143
2024/20251.914 17 46 8 99 287 301 233 178 285 185 158 117
2025/20268.975 341 441 550 337 694 4.661 564 630 238 235 186 98
2026/2027156 64 92 0 0 0 0 0 0 0 0 0 0
Totale 16.076